| Drug Interaction Study (NCT06194864) | Emalex Biosciences Inc. | 2024-01-18 |
| Study of RAS(ON) Inhibitors in Patients With Advanced RAS-mutated NSCLC (NCT06162221) | Revolution Medicines, Inc. | 2024-01-18 |
| A Study of AZD3470, a PRMT5 Inhibitor, Given as Monotherapy and in Combination in Patients With MTAP Deficient Advanced/Metastatic Solid Tumors (NCT06130553) | AstraZeneca | 2024-01-18 |
| A Phase I Clinical Study of ART101 Injection in Healthy Adult Subjects (NCT07529600) | Arnatar Therapeutics, Inc. | 2024-01-18 |
| Safety and Tolerability of 1 Month Daily (1HP) and 3 Months Weekly (3HP) Isoniazid and Rifapentine With Pharmacokinetics of Dolutegravir (DTG) in Pregnant People With HIV (NCT05122026) | The Aurum Institute NPC | 2024-01-17 |
| The Safety, Tolerability and Efficacy of NouvNeu001 for Parkinson's Disease (NCT06167681) | iRegene Therapeutics Co., Ltd. | 2024-01-17 |
| Potential Drug Interaction Study Between Vemircopan and Rosuvastatin, Metformin, Levonorgestrel/Ethinyl Estradiol-containing Oral Contraceptives, and Carbamazepine (NCT06071442) | Alexion Pharmaceuticals, Inc. | 2024-01-17 |
| Study of SIRPant-M in Participants With Relapsed or Refractory Non-Hodgkin's Lymphoma (NCT05967416) | SIRPant Immunotherapeutics, Inc. | 2024-01-17 |
| Efficacy and Safety of Upatinib in the Treatment of Active Anal Fistulas in Crohn's Disease (NCT06902987) | Sixth Affiliated Hospital, Sun Yat-sen University | 2024-01-17 |
| A Study of MK-8507 and Islatravir (MK-8591) in Healthy Adult Participants (MK-8507-016) (NCT06619678) | Merck Sharp & Dohme LLC | 2024-01-17 |
| ATM-Inhibitor WSD0628 in Combination With Radiation Therapy for Treatment of Recurrent High-Grade Glioma (NCT05917145) | Mayo Clinic | 2024-01-17 |
| Phase 1 Study in Diabetes Mellitus(Fasting) (NCT06552182) | Huons Co., Ltd. | 2024-01-17 |
| A Study to Investigate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AZD1705 in Participants With Dyslipidemia (NCT06238466) | AstraZeneca | 2024-01-16 |
| A Study in Healthy People to Compare Two Different Tablets of BI 685509 and to Test How Food and Esomeprazole Influence the Amount of BI 685509 in the Blood (NCT06193811) | Boehringer Ingelheim | 2024-01-16 |
| Radiotherapy in Combination With TTI-101 in Borderline Resectable and Locally Advanced Pancreatic Ductal Adenocarcinoma (NCT06141031) | Washington University School of Medicine | 2024-01-16 |
| A Study to Compare the Pharmacokinetics, Efficacy, Safety, and Immunogenicity of Pembrolizumab (SB27, EU Sourced Keytruda, and US Sourced Keytruda) in Subjects With Stage II-IIIA NSCLC Following Complete Resection and Adjuvant Platinum-based Chemotherapy (NCT06268613) | Samsung Bioepis Co., Ltd. | 2024-01-16 |
| A Multicentre,Study of IBI133 in Subjects WithUnresectable, Locally Advanced or Metastatic SolidTumours (NCT06170190) | Innovent Biologics (Suzhou) Co. Ltd. | 2024-01-16 |
| Study Comparing Once Daily Dose of 900mg of TETA 4HCL Against Cuprior® (450mg Trientine Base, Twice Daily). (NCT06128954) | Orphalan | 2024-01-16 |
| Effect of Dapagliflozin on Metabolomics and Cardiac Mechanics in Chronic Kidney Disease (NCT05719714) | Northwestern University | 2024-01-16 |
| Trial of Tumor Vaccine Used for Adjuvant Therapy in Post Radical Operation Patients With Lung Cancer (NCT03807102) | Yongchang Zhang | 2024-01-16 |
| A SHR0302 BA Study on Healthy Subjects (NCT06202612) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-16 |
| Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study (NCT06274398) | Eastern Virginia Medical School | 2024-01-16 |
| A Clinical Study Evaluating the Safety and Efficacy of Anti-HER2-CAR-T Cells Injection in Patients With Solid Tumors (NCT06101082) | China Medical University, China | 2024-01-16 |
| Dapagliflozin in Nonalcoholic Fatty Liver Disease (NAFLD) and Type 2 Diabetes Mellitus Patients (T2DM). (NCT07020377) | Amira Bisher,PhD | 2024-01-15 |
| A Study to Learn How Different Products of the Study Medicine Called PF-07940367 Are Taken up Into the Blood in Healthy Adults (NCT06190561) | Pfizer | 2024-01-15 |
| A Study of VRG50635 in Participants With Amyotrophic Lateral Sclerosis (ALS) (NCT06215755) | Verge Genomics | 2024-01-15 |
| INS19 CAR-T Cells for the Treatment of Relapsed or Refractory Acute B Lymphoblastic Leukemia (NCT06209671) | Beijing Immunochina Medical Science & Technology Co., Ltd. | 2024-01-15 |
| Deep Brain Stimulation (DBS) for Methamphetamine Use Disorder (NCT05558358) | University of Colorado, Denver | 2024-01-15 |
| Protective Effect of Nicotinamide Riboside Against Acetaminophen Toxicity (NCT06214468) | University of South Alabama | 2024-01-15 |
| A Comparative Study of Intrathecal Dexmedetomidine and Fentanyl As Additives to Bupivacaine in Pott's Fracture (NCT06502262) | Ain Shams University | 2024-01-15 |
| Pharmacokinetics of ZSP1273 in Participants With Severe Kidney Disease (NCT06248567) | Guangdong Raynovent Biotech Co., Ltd | 2024-01-15 |
| A Study to Evaluate the Safety and Immunogenicity of Recombinant Trivalent Poliomyelitis Vaccine (Sf-RVN Cell) in Healthy Adults (NCT06101173) | CanSino Biologics Inc. | 2024-01-15 |
| Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors. (NCT05905341) | Pfizer | 2024-01-15 |
| WBRT With Hippocampal-avoidance Technique Followed by SRT for Extensive-stage SCLC With Baseline Brain Metastases (NCT06243003) | Fudan University | 2024-01-15 |
| Autologous ADMSC Transplantation in Patients With POI (NCT06132542) | Mongolian National University of Medical Sciences | 2024-01-15 |
| CD19 & CD20 Bispecific CAR T Cells for Relapsed / Refractory B Cell Hematological Tumors (NCT06503094) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-01-14 |
| Effect of Rifampicin on the Pharmacokinetics of HRS-1167 in Healthy Subjects (NCT06198556) | Jiangsu HengRui Medicine Co., Ltd. | 2024-01-14 |
| Phase I Study to Assess the Safety and Efficacy of OCU200 for Center-Involved Diabetic Macular Edema (DME) (NCT05802329) | Ocugen | 2024-01-13 |
| A Clinical Study of TQB2618 Injection Monotherapy and Combination Regimen (With Penpulimab Injection ±Anlotinib Hydrochloride Capsules) in the Four or Later Lines of Treatment of Advanced Colorectal Cancer. (NCT06010901) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | 2024-01-13 |
| A Clinical Study of CD19 Universal CAR-γδT Cells in Active Systemic Lupus Erythematosus (NCT06106893) | Union Hospital, Tongji Medical College, Huazhong University of Science and Technology | 2024-01-12 |
| Abemaciclib Plus Darolutamide in Prostate Cancer That Has Spread After Initial Treatment (NCT05999968) | Eli Lilly and Company | 2024-01-12 |
| Allopregnanolone as a Regenerative Treatment for Parkinson's Disease (NCT06263010) | Roberta Brinton | 2024-01-12 |
| FIH, Bispecific CD276xCD3 Antibody CC-3 in Patients With Colorectal Cancer (NCT05999396) | German Cancer Research Center | 2024-01-12 |
| To Compare the Pharmacokinetics, Safety and Immunogenicity of CT-P55 and Cosentyx in Healthy Subjects (NCT07054970) | Celltrion | 2024-01-12 |
| Study of Intramuscular Injections of ABBV-950 to Assess Adverse Events and Change in Disease Activity in Adult Participants With Upper Limb Spasticity (NCT05956509) | AbbVie | 2024-01-12 |
| Lumbar Injectrode Feasibility Evaluation (NCT06206356) | Neuronoff, Inc | 2024-01-12 |
| A Relative Bioavailability Study of LY3454738 in Healthy Participants (NCT06173895) | Eli Lilly and Company | 2024-01-12 |
| CogT pSOPT Intervention Study (NCT06005038) | Stanford University | 2024-01-12 |
| A First Time in Human Study to Evaluate the Safety and Tolerability of GSK3996401 Following Dosing With GSK4347859 in Healthy Participants (NCT06188507) | GlaxoSmithKline | 2024-01-12 |
| A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes (NCT06146257) | GluBio Therapeutics Inc. | 2024-01-11 |
| BT-600 Single and Multiple Ascending Oral Doses in Healthy Adult Subjects (NCT06275464) | Biora Therapeutics, Inc. | 2024-01-11 |
| A Pharmacodynamic Effect Study of AP301 in Healthy Volunteers (NCT06100627) | Alebund Pty Ltd | 2024-01-11 |
| A Study of Copanlisib in Combination with Degarelix in People with Prostate Cancer (NCT06218667) | Memorial Sloan Kettering Cancer Center | 2024-01-11 |
| The Pharmacokinetics of Single Dose Oral Tetrahydrocannabinol and Cannabidiol (NCT05742724) | McMaster University | 2024-01-11 |
| A Study of KQ-2003 CAR-T Cell Therapy for Patients With Relapsed or Refractory Multiple Myeloma (NCT06223646) | Novatim Immune Therapeutics (Zhejiang) Co., Ltd. | 2024-01-11 |
| Bioequivalence Study of Pimavanserin 34 mg Capsule (NCT06450184) | Humanis Saglık Anonim Sirketi | 2024-01-11 |
| A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors (NCT06208410) | Risen (Suzhou) Pharma Tech Co., Ltd. | 2024-01-11 |
| A Clinical Study of T3011 in Combination With PD-1/PD-L1 Inhibitors in Subjects With Advanced Solid Tumors (NCT06214143) | Shanghai Pharmaceuticals Holding Co., Ltd | 2024-01-11 |
| A Study of GLB-002 in Patients With Relapsed or Refractory Non-Hodgkin Lymphomas (NCT06219356) | Hangzhou GluBio Pharmaceutical Co., Ltd. | 2024-01-11 |
| A Phase I Trial of Memory T Cells Expressing an NKG2D Chimeric Antigen Receptor in Children, Adolescents and Young Adults With Advanced Sarcoma (NCT06087341) | Antonio Pérez Martínez | 2024-01-10 |
| A Clinical Research About CD70-targeted CAR-T in the Treatment of CD70-positive Advanced/Metastatic Gynecologic Cancer (NCT06215950) | Chongqing Precision Biotech Co., Ltd | 2024-01-10 |
| A Study of AK131 in Patients With Advanced Solid Tumors (NCT06166888) | Akeso | 2024-01-10 |
| A Study to Assess the Relative Bioavailability of 5 mg Mavacamten Opened Capsule Administered Via Nasogastric Tube Compared to Intact Oral 5 mg Mavacamten in Healthy Participants (NCT06211179) | Bristol-Myers Squibb | 2024-01-10 |
| A Phase 1/2 Study of VIO-01 in Participants With Recurrent Solid Tumors (NCT06257758) | Valerio Therapeutics | 2024-01-10 |
| A Study to Evaluate Potential Drug Interactions Between ALXN2080 and Itraconazole, Fluconazole & Carbamazepine in Healthy Adults (NCT06173596) | Alexion Pharmaceuticals, Inc. | 2024-01-10 |
| TACTIVE-U: A Study to Learn About the Study Medicine (Vepdegestrant) When Given With Other Medicines in People With Advanced or Metastatic Breast Cancer. (Sub-Study C) (NCT06125522) | Pfizer | 2024-01-10 |
| Phase 1/2 Study of IMC-R117C in Selected Advanced Cancers (NCT06840119) | Immunocore Ltd | 2024-01-10 |
| Tulmimetostat (DZR123) in Patients With Mycosis Fungoides and Sézary Syndrome (NCT05944562) | Washington University School of Medicine | 2024-01-09 |
| Study of GS-0201 Alone and in Combination in Participants With Advanced Solid Tumors (NCT06167317) | Gilead Sciences | 2024-01-09 |
| F01 in the Treatment of Autoimmune Diseases (NCT06208280) | RenJi Hospital | 2024-01-09 |
| In-vivo Transmission Model in Semi-immune Adults (NCT06172686) | Ifakara Health Institute | 2024-01-09 |
| Bioequivalence Study of Perindopril Tablets in Healthy Volunteers Under Fasting Conditions (NCT06213610) | Pharmtechnology LLC | 2024-01-09 |
| Autologous Alpha-2 Macroglobulin Rich Plasma, Safety and Efficacy in Symptomatic Moderate Knee Osteoarthritis (NCT06329492) | Mayo Clinic | 2024-01-09 |
| Safety and Efficacy of NRT6008 in Patients With Unresectable Locally Advanced Pancreatic Cancer (LAPC) and Advanced Pancreatic Cancer With Lymph Node Metastases (NCT06278454) | Chengdu New Radiomedicine Technology Co. LTD. | 2024-01-09 |
| Effect of Ev.FV on Wound Healing in Dystrophic Epidermolysis Bullosa (NCT07230223) | Isfahan University of Medical Sciences | 2024-01-09 |
| Combining Anti-PD-L1 Immune Checkpoint Inhibitor Durvalumab With TLR-3 Agonist Rintatolimod in Patients With Metastatic Pancreatic Ductal Adenocarcinoma for Therapy Efficacy (NCT05927142) | Joachim Aerts, MD PhD | 2024-01-09 |
| Safety Study of GMDTC Injection in Participants With Excessive Cadmium (NCT06199349) | Jianersheng (Zhuhai) Pharmaceutical Technology Co., Ltd. | 2024-01-08 |
| The Effect of Oral Gan Shuangbi During the Perinatal Period on the Recovery of Intestinal Function After Cesarean Section in Pregnant Women- A Multicenter, Double-blind, Randomized Controlled Clinical Trial (NCT06347770) | Zhe Li | 2024-01-08 |
| MTC Versus FMT in for RCDI (NCT05911997) | Icahn School of Medicine at Mount Sinai | 2024-01-08 |
| A Study of Glofitamab and Lenalidomide in People With Mantle Cell Lymphoma (NCT06192888) | Memorial Sloan Kettering Cancer Center | 2024-01-08 |
| IAMA-6 Oral Dose Study in Healthy Adults (NCT06300398) | Iama Therapeutics S.r.l. | 2024-01-08 |
| First-in-human Study to Evaluate the Safety and Immunogenicity of Three Dose Levels of the OVX033 Coronavirus Vaccine Candidate in Healthy Volunteers (NCT06128382) | Osivax | 2024-01-08 |
| CAR-monocytes for the Treatment of HER2 Overexpressing Solid Tumors (NCT06254807) | Carisma Therapeutics Inc | 2024-01-08 |
| Study to Evaluate the Safety, Pharmacokinetics, and Activity of GDC-1971 in Combination With Either Osimertinib in Participants With Unresectable, Locally Advanced, or Metastatic Non-Small Cell Lung Cancer, or With Cetuximab in Participants With Metastatic Colorectal Cancer (NCT05954871) | Genentech, Inc. | 2024-01-08 |
| A Single Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SYH2053 (NCT06229548) | CSPC Zhongnuo Pharmaceutical (Shijiazhuang) Co., Ltd. | 2024-01-08 |
| A Phase 1/1b Study of ZH9 Treatment in Patients With Non-Muscle Invasive Bladder Cancer (NCT06181266) | Prokarium Ltd | 2024-01-08 |
| Durvalumab and Grid Therapy for Non-small Cell Lung Cancer in Progression During or After Treatment With PACIFIC Regimen (NCT05443971) | Mayo Clinic | 2024-01-08 |
| Venetoclax, Daratumumab, and Dexamethasone for Systemic Light-Chain Amyloidosis With Translocation (11;14) (ALTITUDE) (NCT05486481) | Alfred Chung, MD | 2024-01-08 |
| PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) (NCT04754061) | Ottawa Hospital Research Institute | 2024-01-08 |
| A Study to Learn if Elinzanetant Affects the Ability to Drive and Brain Function in Healthy Women (NCT06219902) | Bayer | 2024-01-08 |
| Anti-viral T-cell Therapy by Gamma Capture (NCT06027879) | Paul Szabolcs | 2024-01-08 |
| ITGA6 Targeting NIR-II Fluorescence Image Guided Surgery (NCT06204835) | Institute of Automation, Chinese Academy of Sciences | 2024-01-07 |
| JAG201 Gene Therapy Study in Children & Adults With SHANK3 Haploinsufficiency (NCT06662188) | Jaguar Gene Therapy, LLC | 2024-01-07 |
| A Study of KD6005 in Healthy Participants and Participants With Rheumatoid Arthritis (RA) (NCT06213259) | Shanghai Kanda Biotechnology Co., Ltd. | 2024-01-06 |
| A Study of NWY001 in Subjects With Advanced Solid Tumors (NCT05979155) | Chipscreen Biosciences, Ltd. | 2024-01-05 |
| A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130850 in Participants With Advanced Solid and Hematologic Tumors (NCT06188208) | Vividion Therapeutics, Inc. | 2024-01-05 |
| A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major (NCT06465550) | Shanghai BDgene Co., Ltd. | 2024-01-05 |
| Efficacy and Safety of Different Dose Regimens of Gabapentin for Treating Erythema/Flushing in Rosacea: A Randomized Controlled Trial (NCT06776445) | First Affiliated Hospital of Chongqing Medical University | 2024-01-05 |
| Exploring the Use of Phototherapy to Improve CPAP Compliance (NCT06960161) | University of Alberta | 2024-01-05 |
| Intravenous Vesicular Stomatitis Virus in Patients With Peripheral T-cell Lymphoma (NCT06508463) | Mayo Clinic | 2024-01-05 |